Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Carysil

WEBSITE BSE:524091 NSE: CARYSIL Inc. Year: 1987 Industry: Household & Personal Products My Bucket: Add Stock

₹863.4 -38 | 4.2%

Last updated: 15:55

Consolidated Standalone

Last updated: 15:55

Carysil Overview

Acrysil Limited, collectively with its subsidiaries, manufactures and trades in kitchen sinks and appliances, tub products, tiles, and accessories in India. The company gives quartz sinks, stainless-steel sinks, and wash basins; home equipment, together with taps, chimneys, hobs, ovens, cook dinner tops, wine chillers, food waste disposers, dishwashers, wine chiller, and hoods; 3-D tiles; and bathroom suites underneath the Carysil and Sternhagen emblem names. It additionally imports and markets kitchen sinks; and deals in quartz sinks, metallic...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Carysil Key Financials

Market Cap ₹2456 Cr.

Stock P/E 38.2

P/B 4.2

Current Price ₹863.4

Book Value ₹ 206.4

Face Value 2

52W High ₹1071.5

Dividend Yield 0.28%

52W Low ₹ 581.7

Edit Ratio

Carysil Share Price

₹ | |

Volume
Price

Carysil Quarterly Price

Quarterly Monthly
Show Value Show %

Carysil Peer Comparison

Carysil Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 164 188 191 201 207 203 204 227 241 223
Other Income 1 1 2 1 2 4 2 1 5 3
Total Income 165 189 192 203 209 207 206 228 245 225
Total Expenditure 131 153 156 165 170 174 169 183 195 180
Operating Profit 34 36 36 37 39 33 37 45 51 45
Interest 5 6 6 6 6 6 5 5 5 5
Depreciation 8 8 9 9 10 9 8 9 10 10
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -1
Profit Before Tax 22 22 21 23 24 18 24 30 36 29
Provision for Tax 6 7 5 7 6 6 5 7 9 8
Profit After Tax 16 15 16 16 17 13 19 23 27 21
Adjustments -0 -0 -0 0 -0 -0 -0 -0 -0 -0
Profit After Adjustments 15 15 16 16 17 13 19 23 27 21
Adjusted Earnings Per Share 5.8 5.7 5.8 5.9 5.9 4.4 6.5 8 9.6 7.4

Carysil Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 127 174 181 196 252 276 310 484 594 684 816 895
Other Income 1 2 3 5 2 5 8 10 2 5 10 11
Total Income 128 176 184 201 254 281 318 494 595 689 825 904
Total Expenditure 103 143 154 169 209 229 243 379 484 553 676 727
Operating Profit 25 32 29 32 45 52 75 115 111 136 150 178
Interest 8 9 11 8 12 10 8 11 17 23 26 20
Depreciation 4 5 6 7 9 12 13 18 26 32 36 37
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 -1
Profit Before Tax 13 18 13 17 24 30 54 86 68 81 88 119
Provision for Tax 4 6 5 5 7 8 15 21 15 22 24 29
Profit After Tax 9 12 8 12 17 23 39 65 53 58 64 90
Adjustments -0 -1 -1 -0 -0 -1 -0 -0 -0 -0 -1 0
Profit After Adjustments 9 11 7 12 17 22 39 65 52 58 64 90
Adjusted Earnings Per Share 3.7 4.2 2.8 4.6 6.6 8.3 14.7 24.3 19.6 21.6 22.4 31.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 19% 19% 24% 20%
Operating Profit CAGR 10% 9% 24% 20%
PAT CAGR 10% -1% 23% 22%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 40% 12% 23% 23%
ROE Average 15% 17% 21% 18%
ROCE Average 16% 17% 21% 19%

Carysil Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 42 80 112 118 135 158 191 254 303 354 527
Minority's Interest 3 2 2 1 2 2 3 3 4 4 5
Borrowings 27 22 20 19 17 21 22 39 78 115 89
Other Non-Current Liabilities 2 3 2 3 3 3 9 15 17 17 15
Total Current Liabilities 74 93 105 128 135 140 166 243 310 355 350
Total Liabilities 147 199 240 269 291 325 391 553 712 845 985
Fixed Assets 58 67 98 111 119 125 152 206 328 404 414
Other Non-Current Assets 6 4 6 6 7 14 18 39 31 27 45
Total Current Assets 82 128 136 152 164 186 221 308 353 414 526
Total Assets 147 199 240 269 291 325 391 553 712 845 985

Carysil Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 6 28 22 3 5 6 8 5 4 9
Cash Flow from Operating Activities 7 11 6 16 24 30 45 52 71 53 60
Cash Flow from Investing Activities -27 -13 -14 -20 -17 -19 -35 -73 -136 -97 -109
Cash Flow from Financing Activities 25 19 2 -0 -4 -10 -9 18 64 48 53
Net Cash Inflow / Outflow 5 17 -6 -5 2 1 2 -2 -1 5 4
Closing Cash & Cash Equivalent 6 23 22 17 5 6 8 5 4 9 13

Carysil Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.75 4.21 2.8 4.61 6.65 8.27 14.66 24.26 19.58 21.6 22.44
CEPS(Rs) 5.7 6.77 5.26 7.47 10.07 13.03 19.47 31.08 29.58 33.88 35.29
DPS(Rs) 0.8 1 1 1 1.2 1.2 2 2.4 2 2 2.4
Book NAV/Share(Rs) 17.89 30.68 43.06 45.6 51.2 59.12 71.7 93.65 112.35 131.45 185.11
Core EBITDA Margin(%) 18.52 17.01 14.89 13.74 16.85 17.23 21.6 21.63 18.44 19.13 17.16
EBIT Margin(%) 15.8 14.98 13.16 12.45 14.26 14.63 20.09 20.04 14.27 15.17 13.96
Pre Tax Margin(%) 10 9.9 7.01 8.59 9.62 11.03 17.38 17.79 11.47 11.81 10.77
PAT Margin (%) 6.84 6.77 4.41 6.23 6.95 8.28 12.69 13.49 8.9 8.54 7.89
Cash Profit Margin (%) 10.08 9.8 7.54 9.86 10.38 12.59 16.78 17.15 13.33 13.28 12.29
ROA(%) 7.41 7.02 3.63 4.88 6.25 7.43 10.99 13.82 8.35 7.5 7.03
ROE(%) 23.94 20.03 8.33 10.64 13.92 15.73 22.52 29.57 19.18 17.87 14.65
ROCE(%) 22.16 20.56 14.06 12.18 16.25 16.45 22.53 28.38 18.52 17.63 15.77
Receivable days 79.45 76.18 81.39 80.19 74.33 77.03 85.61 69.17 62.51 64.28 63.51
Inventory Days 76.69 67.72 76.47 82.87 73.89 74.95 67.35 59.88 72.15 81.07 88.24
Payable days 116.47 129.47 155.54 141.77 115.17 93.97 110.49 131.01 104.51 106.11 88.56
PER(x) 29.1 23.02 38.85 22.53 16.68 6.77 21.13 34.25 27.75 45.44 27.84
Price/Book(x) 6.1 3.16 2.52 2.28 2.17 0.95 4.32 8.87 4.84 7.47 3.38
Dividend Yield(%) 0.73 1.03 0.92 0.96 1.08 2.14 0.65 0.29 0.37 0.2 0.38
EV/Net Sales(x) 2.52 1.67 1.88 1.75 1.47 0.84 2.93 4.84 2.8 4.26 2.42
EV/Core EBITDA(x) 12.78 8.97 11.53 10.87 8.32 4.43 12.12 20.43 14.97 21.42 13.17
Net Sales Growth(%) 19.39 36.76 4.12 8.55 28.06 9.79 12.12 56.24 22.73 15.13 19.28
EBIT Growth(%) 36.88 29.23 -11.41 2.73 46.67 12.63 53.99 55.87 -12.64 22.37 9.79
PAT Growth(%) 16.41 34.8 -34.36 53.49 42.86 30.77 71.98 65.97 -19.04 10.47 10.21
EPS Growth(%) 9.42 12.19 -33.47 64.63 44.33 24.39 77.23 65.53 -19.29 10.32 3.9
Debt/Equity(x) 1.75 0.84 0.72 0.77 0.73 0.65 0.53 0.55 0.73 0.85 0.5
Current Ratio(x) 1.12 1.38 1.3 1.18 1.22 1.33 1.33 1.27 1.14 1.17 1.51
Quick Ratio(x) 0.69 1.01 0.9 0.81 0.82 0.9 1 0.84 0.72 0.68 0.87
Interest Cover(x) 2.72 2.95 2.14 3.23 3.07 4.07 7.41 8.88 5.09 4.52 4.38
Total Debt/Mcap(x) 0.29 0.27 0.28 0.34 0.34 0.68 0.12 0.06 0.15 0.11 0.15

Carysil Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 43.84 43.84 43.79 41.37 41.37 41.37 41.33 41.33 41.33 41.33
FII 0.64 0.87 0.7 1.22 1.29 1.26 1.54 1.44 1.55 1.59
DII 9.08 7.32 7.2 11.08 11.68 11.56 11.19 11.33 11.34 11.73
Public 46.45 47.98 48.31 46.32 45.65 45.8 45.93 45.89 45.78 45.34
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Carysil News

Carysil Pros & Cons

Pros

  • Company has delivered good profit growth of 22% CAGR over last 5 years
  • Debtor days have improved from 106.11 to 88.56days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 41.33%.
  • Stock is trading at 4.2 times its book value.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!